全球七成医疗器械中国贴牌制造

2015-05-29 佚名 北京商报

日前在上海举行的第七届中国医疗器械行业发展论坛上,中国医药保健品进出口商会副秘书长蔡天智指出,“2014年世界医疗器械市场70%的产品是中国企业制造的,但未必是中国企业的牌子,可能是通过OEM方式进入的。中国有自己知识产权的品牌很少”。中国诊疗设备仍是逆差2014年我国经济增速放缓,驱动产业升级,结构调整中更加重视“质量”方面的转变,向着更均衡、更高值、更持久的方面增长。“我国经济进入新常态,20

日前在上海举行的第七届中国医疗器械行业发展论坛上,中国医药保健品进出口商会副秘书长蔡天智指出,“2014年世界医疗器械市场70%的产品是中国企业制造的,但未必是中国企业的牌子,可能是通过OEM方式进入的。中国有自己知识产权的品牌很少”。

中国诊疗设备仍是逆差

2014年我国经济增速放缓,驱动产业升级,结构调整中更加重视“质量”方面的转变,向着更均衡、更高值、更持久的方面增长。“我国经济进入新常态,2014年医疗器械对外贸易增速放缓。2014年中国医疗器械出口200.23亿美元,同比增加3.56%,增速下降了6.36个百分点。2014年中国医疗器械进口157.71亿美元,同比增长5.52%,增速下降了14.75个百分点。”蔡天智说。

2014年我国医疗器械贸易顺差为42.52亿美元,其中医用耗材、医用敷料、保健康复、口腔设材等四类处于顺差,而诊疗设备出口为89.55亿美元,进口为113.95亿美元。“中国诊疗设备还是逆差。”诊疗设备有X射线诊断设备、超声诊断设备、功能检查设备、内窥镜检查设备、核医学设备、实验诊断设备及病理诊断装备等,大多属于高性能医疗器械。

蔡天智解析:“2014年,70%世界医疗器械产品是中国企业制造的,但未必是中国企业的牌子,可能是通过OEM方式进入的(OEM指的是定牌或者贴牌生产)。”据了解,我国高端医疗器械主要靠进口,检验设备出口占85%,心电图出口占90%,中高端监护占到80%,高档生理记录占到90%。

“一带一路”有助于产生中国品牌

“我国产品的特点是知识产权少,自有品牌少。”蔡天智表示。国家提倡的“一带一路”战略,为中国发展自主品牌的医疗器械提供了环境和条件。“一带一路”覆盖了44亿人口,这些国家和地区的国民生产总值为21万亿美元。我国出口到亚洲国家的医疗器械占整个出口市场的33.12%,而我国需要从中亚国家进口大量的医疗器械原料,与其这样,不如把高分子类产品直接输入到中亚国家,在那里进行组装,在当地进行销售。

蔡天智认为,随着中国经济进入新常态,企业家将更多的精力放到产品创新与质量控制两方面,一是对专利保护意识将增强,二是对产品稳定性、均一性要求更高,三是产学研联盟意愿更强烈,四是推广将进入实效。

2015年贸易额达400亿美元

2015年医疗器械国家市场将摒弃同质化价格竞争转向差异化质量竞争,对行业在结构调整和市场结构优化方面起到引导作用,势必影响我国企业参与全球价值链的专业化水平。WTO推进贸易便利化,将为“质优可信”的中国产品进一步拓展国际贸易市场提供便利。

蔡天智预测,2015年中国外贸发展的国际、国内环境并没有根本性改善,但外贸发展也有很多机遇,2015年中国对外贸易将有望实现与GDP基本同步的增长速度,与经济新常态相匹配,2015年中国医疗器械贸易额可达400亿美元。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=25539, encodeId=1e3c2553955, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:05:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25384, encodeId=678a253840d, content=必需更加努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25385, encodeId=8cb12538536, content=搞研发品牌才有出路!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25355, encodeId=850525355b8, content=自己品牌不信, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sat May 30 06:29:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25276, encodeId=53ac252e684, content=世界工厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Fri May 29 12:22:00 CST 2015, time=2015-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25270, encodeId=5b5a252e019, content=只有, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 11:46:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-05-31 huaxipanxing

    看看

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=25539, encodeId=1e3c2553955, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:05:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25384, encodeId=678a253840d, content=必需更加努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25385, encodeId=8cb12538536, content=搞研发品牌才有出路!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25355, encodeId=850525355b8, content=自己品牌不信, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sat May 30 06:29:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25276, encodeId=53ac252e684, content=世界工厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Fri May 29 12:22:00 CST 2015, time=2015-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25270, encodeId=5b5a252e019, content=只有, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 11:46:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-05-30 yydlt

    必需更加努力!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=25539, encodeId=1e3c2553955, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:05:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25384, encodeId=678a253840d, content=必需更加努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25385, encodeId=8cb12538536, content=搞研发品牌才有出路!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25355, encodeId=850525355b8, content=自己品牌不信, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sat May 30 06:29:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25276, encodeId=53ac252e684, content=世界工厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Fri May 29 12:22:00 CST 2015, time=2015-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25270, encodeId=5b5a252e019, content=只有, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 11:46:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-05-30 yydlt

    搞研发品牌才有出路!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=25539, encodeId=1e3c2553955, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:05:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25384, encodeId=678a253840d, content=必需更加努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25385, encodeId=8cb12538536, content=搞研发品牌才有出路!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25355, encodeId=850525355b8, content=自己品牌不信, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sat May 30 06:29:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25276, encodeId=53ac252e684, content=世界工厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Fri May 29 12:22:00 CST 2015, time=2015-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25270, encodeId=5b5a252e019, content=只有, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 11:46:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-05-30 hbwang006

    自己品牌不信

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=25539, encodeId=1e3c2553955, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:05:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25384, encodeId=678a253840d, content=必需更加努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25385, encodeId=8cb12538536, content=搞研发品牌才有出路!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25355, encodeId=850525355b8, content=自己品牌不信, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sat May 30 06:29:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25276, encodeId=53ac252e684, content=世界工厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Fri May 29 12:22:00 CST 2015, time=2015-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25270, encodeId=5b5a252e019, content=只有, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 11:46:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-05-29 Dr.LV

    世界工厂

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=25539, encodeId=1e3c2553955, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sun May 31 21:05:00 CST 2015, time=2015-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25384, encodeId=678a253840d, content=必需更加努力!, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25385, encodeId=8cb12538536, content=搞研发品牌才有出路!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yydlt, createdTime=Sat May 30 10:13:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25355, encodeId=850525355b8, content=自己品牌不信, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=hbwang006, createdTime=Sat May 30 06:29:00 CST 2015, time=2015-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25276, encodeId=53ac252e684, content=世界工厂, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=Dr.LV, createdTime=Fri May 29 12:22:00 CST 2015, time=2015-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=25270, encodeId=5b5a252e019, content=只有, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri May 29 11:46:00 CST 2015, time=2015-05-29, status=1, ipAttribution=)]
    2015-05-29 MedSci客户端网友

    只有

    0

相关资讯

2014医疗器械市值涨幅TOP10 分子诊断热门

Fierce Medical Devices盘点了估值超过20亿美金的医疗设备和诊断公司,列举2014年市值增长率的TOP10。让我们来看看:为什么这些公司能让股市飞。 在过去三年中,投资者对医疗器械和诊断设备的兴趣持续升温。Fierce Medical Devices盘点了估值超过20亿美金的医疗设备和诊断公司,列举2014年市值增长率的TOP10。让我们来看看:为什么这些公司能让

《医疗器械监督管理条例》出台 6月1日起施行

国家食品药品监督管理总局与国务院法制办31日在京联合召开宣传贯彻《医疗器械监督管理条例》新闻发布会。新修订的《医疗器械监督管理条例》已于2014年2月12日经国务院常务会议审议通过,将于6月1日起施行。国家食品药品监督管理总局食品药品安全总监焦红、国务院法制办教科文卫司司长王振江出席发布会,介绍《条例》修订情况,并对《条例》的贯彻实施提出具体要求。新修订《条例》共8章80条,《条例》的修订体现了党

食药监总局:没有能治愈糖尿病高血压的医疗器械

国家食药监总局办公厅主任颜江瑛17日指出,一些无证经销医疗器械打着免费体验的招牌进行夸大宣传,误导了很多老年人。这类违法违规宣传是此次行动重点打击的内容之一,到目前为止,没有一个医疗器械能够治愈糖尿病和高血压。国家食药监总局17日上午举行新闻发布会,介绍医疗器械“五整治”专项行动有关情况。食药监总局稽查局局长毛振宾介绍,作为监管部门,对违法违规广告的整治主要有以下几方面内容。第一,把住广告审查的源

食品药品监管总局关于印发创新医疗器械特别审批程序(试行)的通知

食品药品监管总局关于印发创新医疗器械特别审批程序(试行)的通知食药监械管〔2014〕13号 各省、自治区、直辖市食品药品监督管理局:  为了保障医疗器械的安全、有效,鼓励医疗器械的研究与创新,促进医疗器械新技术的推广和应用,推动医疗器械产业发展,总局组织制定了《创新医疗器械特别审批程序(试行)》,现印发给你们,请遵照执行。                           国家食品药品监督

食药监总局通报医疗器械整治中10起重大典型案件

人民网北京7月8日电 据国家食品药品监督管理总局网站消息,今日,国家食品药品监管总局召开医疗器械“五整治”专项行动新闻发布会,通报了专项行动期间整治虚假广告、查处违法案件等方面情况。 据悉,医疗器械“五整治”专项行动期间,国家食品药品监管总局针对案件易发的重点领域、重点环节、重点品种,严打制假售假违法行为,严惩发布严重违法广告生产经营企业,及时移送、公开曝光,保持了高压震慑态势,取得了阶段性成

微创医疗18亿元收购美国企业 医疗器械行业掀“出海潮”

记者日前从微创医疗获悉,该公司已完成对美国Wright公司关节重建业务资产的收购,总交易金额达到2.9亿美元(约合18亿元人民币)。这意味着国内医疗器械行业最大一笔海外并购项目的敲定,同时也将2013年以来医疗器械企业的“出海热”推向高潮。总部位于上海张江的微创医疗是国内心血管支架领域的龙头企业,去年上半年营业收入达到4.22亿元。此次收购的Wright公司资产,年销售额约2.7亿美元(16亿元人